Rhumbline Advisers Stereotaxis, Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 148,913 shares of STXS stock, worth $396,108. This represents 0.0% of its overall portfolio holdings.
Number of Shares
148,913
Previous 45,997
223.75%
Holding current value
$396,108
Previous $80,000
293.75%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding STXS
# of Institutions
95Shares Held
42MCall Options Held
37.3KPut Options Held
18.6K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$36.4 Million8.43% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.69MShares$12.5 Million5.81% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$9.42 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.3MShares$8.78 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.85MShares$7.59 Million14.02% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $199M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...